Cancer Gene Therapy
Institute for Digestive Medicine details research in cancer gene therapy
Published in Cancer Weekly, October 7th, 2008
A report, 'AAV-HGFK1 and Ad-p53 cocktail therapy prolongs survival of mice with colon cancer,' is newly published data in Molecular Cancer Therapeutics. "This study tried to evaluate the application of a novel cancer gene therapy using recombinant adeno-associated virus (AAV) carrying the kringle 1 domain of human hepatocyte growth factor (AAV-HGFK1) in combination with recombinant adenovirus carrying p53 gene (Ad-p53). BALB/c and nude mice models of colon cancer were established and the mice were treated with AAV-HGFK1 alone or in combination with Ad-p53," researchers in Taiwan report.
"Combination of AAV-HGFK1 and Ad-p53 significantly prolonged the survival of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2008-10-07)
More Articles from Cancer Weekly
- World Journal of Gastroenterology
A new therapeutic option for human hepatocyte cancer - Cancer
Book Proceeds Help Cancer Patients at Phoenix Children's Hospital - Cancer
Eating Walnuts Slows Cancer Growth, Laboratory Study Finds - Cancer Gene Therapy
Studies in the area of cancer gene therapy reported from P. Yu and co-researchers - Cancer Vaccines
Research from College of Medicine provide new insights into cancer vaccines - Celsion Corporation
Celsion Provides Update on Its Global Pivotal Phase III Primary Liver Cancer Trial - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
